GI highlights from the literature
[...]this study demonstrates that HPCs can functionally repopulate large areas of liver parenchyma. Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: a cohort study of 53,500 subjects. HBV infection remains a global health problem; 350-400 million people worldwide...
Saved in:
Published in | Gut Vol. 64; no. 12; pp. 1999 - 2000 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.12.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0017-5749 1468-3288 |
DOI | 10.1136/gutjnl-2015-310810 |
Cover
Loading…
Summary: | [...]this study demonstrates that HPCs can functionally repopulate large areas of liver parenchyma. Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: a cohort study of 53,500 subjects. HBV infection remains a global health problem; 350-400 million people worldwide are estimated to be chronically infected, with rising rates of decompensated liver disease, hepatocellular carcinoma (HCC)-related and HBV-related deaths. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0017-5749 1468-3288 |
DOI: | 10.1136/gutjnl-2015-310810 |